On January 27, 2023, Fever Labs, Inc. closed the transaction. The company has raised $41,500,008 in the second and final tranche. The company has raised total of $110,000,000 in the transaction.

The transaction included participation from returning investor, Goldman Sachs Asset Management, L.P and Eurazeo SE. The round is raised at a post money valuation of $1,800,000,000.